Literature DB >> 12427889

Megalencephaly in NF1: predominantly white matter contribution and mitigation by ADHD.

L E Cutting1, K L Cooper, C W Koth, S H Mostofsky, W R Kates, M B Denckla, W E Kaufmann.   

Abstract

BACKGROUND: Megalencephaly is a frequent CNS manifestation in neurofibromatosis type 1 (NF1); however, its tissue composition, modification by attention deficit hyperactivity disorder (ADHD), and relationship with unidentified bright objects (UBO) remain controversial.
METHODS: Eighteen male patients with NF1, seven of whom had ADHD (NF1+ADHD), were compared with 18 age- and sex-matched controls in terms of MRI-, Talairach-based brain, cerebral, lobar, and sublobar gray and white matter volumes. Twelve subjects with NF1 had UBO in the centrencephalic region, whereas six had no UBO or exclusively infratentorial lesions.
RESULTS: Patients with NF1 without ADHD (NF1-pure) had the largest total cerebral, gray, and white matter volumes with larger parietal/somatosensory white matter volumes than controls, particularly if UBO were present in the basal ganglia. All subjects with NF1 (including NF1+ADHD) had larger total and frontal white matter volumes than controls. Smaller frontal/right prefrontal gray matter volumes were found in NF1+ADHD when compared with NF1-pure patients.
CONCLUSIONS: The increase in frontal and parietal white matter volumes in male patients with NF1, including the preferential centrencephalic distribution, supports the hypothesis that NF1's white matter pathology encompasses but is not limited to visible UBO. Male patients with NF1+ADHD, as compared with NF1-pure patients, showed frontal reductions that are largely consistent with those found in idiopathic ADHD.

Entities:  

Mesh:

Year:  2002        PMID: 12427889     DOI: 10.1212/01.wnl.0000032370.68306.8a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

2.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

Review 3.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

4.  Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.

Authors:  Federico Nemmi; Fabien Cignetti; Christine Assaiante; Stephanie Maziero; Fredrique Audic; Patrice Péran; Yves Chaix
Journal:  Hum Brain Mapp       Date:  2019-05-11       Impact factor: 5.038

5.  Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.

Authors:  Matthew J Barkovich; Chin Hong Tan; Ryan M Nillo; Yi Li; Duan Xu; Christine M Glastonbury; Orit A Glenn; William P Dillon; Christopher P Hess; Sabine Mueller; Cassie Kline; Anders M Dale; Terry L Jernigan; Leo P Sugrue; A James Barkovich; Rahul S Desikan
Journal:  Radiology       Date:  2018-09-04       Impact factor: 11.105

6.  Functional Connectivity Changes and Executive and Social Problems in Neurofibromatosis Type I.

Authors:  Marisa Loitfelder; Stephan C J Huijbregts; Ilya Milos Veer; Hanna S Swaab; Mark A Van Buchem; Reinhold Schmidt; Serge A Rombouts
Journal:  Brain Connect       Date:  2015-03-31

7.  Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.

Authors:  João V Duarte; Maria J Ribeiro; Inês R Violante; Gil Cunha; Eduardo Silva; Miguel Castelo-Branco
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

8.  Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.

Authors:  Balazs Hegedus; Tu-Hsueh Yeh; Da Yong Lee; Ryan J Emnett; Jia Li; David H Gutmann
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

9.  Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Authors:  Steffie N Tomson; Matthew J Schreiner; Manjari Narayan; Tena Rosser; Nicole Enrique; Alcino J Silva; Genevera I Allen; Susan Y Bookheimer; Carrie E Bearden
Journal:  Hum Brain Mapp       Date:  2015-08-25       Impact factor: 5.038

10.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.